DJ AbbVie Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ shed 1.16% to $227.45 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.83% to 6,795.99 and the Dow Jones Industrial Average rising 0.50% to 47,740.80.
This was the stock's third consecutive day of losses.
AbbVie Inc. closed 7.09% short of its 52-week high of $244.81, which the company achieved on October 1st.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.91% to $242.59, Pfizer Inc. $(PFE)$ fell 0.89% to $26.81, and Amgen Inc. $(AMGN)$ rose 2.01% to $376.97.
Trading volume (7.8 M) eclipsed its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 09, 2026 16:32 ET (20:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments